Educational research summary. Benefits and risks depend on the exact product, condition and person. This article has not been reviewed by a medical professional.
Two questions that should stay separate
“What does this molecule do in the body?” and “Should a person take it?” are separate questions. The first can be explored through tissue sampling, cell experiments and animal work. The second requires direct evidence about administered products, patient outcomes and harms.
A useful research summary names the experimental species and separates an association from an intervention. It also distinguishes the native peptide from an analogue or a product sold under a similar name.
What did the landmark study actually test?
Reynolds and colleagues reported improved physical performance after MOTS-c treatment in mice. Their human work observed exercise-related changes in naturally occurring MOTS-c. It did not demonstrate that MOTS-c injections improve human healthspan. Reynolds et al., 2021: MOTS-c, exercise and aging ↗
Why should readers look for replication?
Another human exercise study found increased circulating humanin after acute endurance exercise, while the MOTS-c change was a trend. Exercise mode, timing and measurement methods matter when comparing findings. These experiments measured exercise responses; they were not evidence for a commercial injection protocol. von Walden et al., 2021: Exercise and mitochondrial peptides ↗
What evidence would change the discussion?
A meaningful treatment study would define its product, study population, comparison and outcomes in advance. It would report adverse events, missing data and follow-up, and use outcomes relevant to patients rather than relying only on a molecular signal.
Look for a completed study and results, not only a trial registration, company announcement or proposed mechanism. A trial involving an analogue cannot automatically validate a different product marketed as MOTS-c.
Read across related topics carefully
The related-owner Bimini mitochondrial-health explainer offers a separate perspective on exercise and recovery. It is a brand-published resource, not independent validation of peptide treatment or proof that hydrotherapy and peptides work together. See our recovery evidence guide for how we separate those claims.
Common questions
Is exercise-induced MOTS-c evidence for injections?
No. Measuring a naturally occurring molecule after exercise does not establish the effects or safety of administering it.
Is a registered trial proof that a treatment works?
No. Registration describes a planned study. Evaluate its completion, published results, methods and harms.
Sources & further reading
- Reynolds et al., 2021: MOTS-c, exercise and aging ↗
- von Walden et al., 2021: Exercise and mitochondrial peptides ↗
Sources checked November 10, 2026. This is a focused source summary, not a systematic review. Regulatory information can change. Read the editorial policy.
Continue exploring
Peptides & longevity: what would actually count as proof? ↗
GLP-1 medicines, muscle & healthspan: look beyond the scale ↗
Recovery peptides & hydrotherapy: compare the evidence before combining them ↗